Bio News
The U.S. Food and Drug Administration (FDA) has issued a direct final rule stating that nonanimal testing methods may be used instead of animal studies to evaluate drug safety.
The revision replaces the terms animal testing and preclinical terminology with nonclinical testing and nonclinical research, respectively, and adds related definitions to the regulations.
The FDA plans to accept comments from Sept. 22 through Dec. 7 and finalize the effective date within 30 days.
BIOBOOK TEAM
biobookmedia@biobook.co.krIonkura Reports 20.8-Month Median Survival in Phase 1 Trial for Metastatic Eye Cancer
Verastem’s VS-7375 Shows Response Rates of Up to 50% in Pancreatic Cancer; Phase 3 Trial to Begin This Year
Pfizer to Co-Develop Sec61 Inhibitors With Enodia in Deal Worth Up to $500 Million
Galderma to Acquire ZO Skin Health for $1.5 Billion, Expanding Dermatology Portfolio
Verdiva halts GLP-1 transition trial, citing ‘market changes’
Stryker to Invest $400 Million in CMR Surgical, Expand Robotic Surgery
